Eliquis (apixaban)

pCPA File Number: 20717
Negotiation Status:
Concluded with an LOI
Indication(s):
Thromboembolic events prevention, (atrial fibrillation)
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
SR0288-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: